Laurent Doucet

Laurent Doucet is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Senior Director Global Brand Execution Lead for Oncology and Senior Director Global Launch Excellence for Inflammation at Gilead Sciences since December 2019. Prior to this, Laurent was an Independent Consultant at Glycine Limited, offering strategic consultancy to startups and pharmaceutical companies from January 2019 to August 2020. Laurent held the position of Managing Director Europe at Human Care Systems, Inc. in 2018, leading a team focused on patient support programs in multiple therapeutic areas. A significant tenure at Eli Lilly and Company spanned from 2005 to 2017, where Laurent advanced through various roles, culminating as Senior Business Unit Director for Diabetes in France, Belgium, and The Netherlands. Earlier experience includes strategic marketing roles at startups like Xelya and GridXpert, as well as a consultancy role at Accenture. Education includes an MBA from INSEAD, studies at Télécom Paris, and École Polytechnique, along with a forthcoming certification from the Cialdini Institute.